HITI
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
Next report
Analyst consensus
- Next report date
- Sep 14, 2026
- EPS estimate
- $0.01
- Revenue estimate
- $138.8M
Latest reported
- Last report date
- Jun 16, 2026
- EPS actual
- $0.01
- EPS estimate
- -$0.02
- Revenue actual
- $131.9M
- Revenue estimate
- $125.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +227.4%
- Revenue beats (12Q)
- 4
Q2 FY2026 · Jun 16, 2026
AI summary of management’s prepared remarks and analyst Q&A · For informational purposes only, not investment advice
Management highlights
No managerial statements or operational highlights were shared in the provided partial transcript, as the call had not started when the transcript cut off.
Guidance
No forward-looking guidance statements were included in the partial transcript.
Segment performance
No segment performance data was provided in the partial transcript.
Risks & headwinds
No discussion of risks or operational failures was included in the provided partial transcript.
Analyst Q&A
No question and answer section content was provided in the partial transcript.
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 14, 2026